NUFARM LIMITED — Director's Dealing 2017

Nov 13, 2017

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity NUFARM LIMITED ABN 37 091 323 312

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	WILLIAM BRUCE GOODFELLOW
Date of last notice	5/5/2017

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Sulkem Company Ltd
Date of change	10/11/2017

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	Direct: 144,888 Fully Paid Ordinary Shares Indirect: MA Goodfellow – 13,000 Fully Paid Ordinary Shares and 100 NSS St Kentigern Trust – 430,434 Fully Paid Ordinary Shares and 19,727 NSS Sulkem Company Ltd – 129,787 Fully Paid Ordinary Shares Auckland Medical Research Foundation – 26,558 NSS Trustees of The Goodfellow Foundation – 33,854 Fully Paid Ordinary Shares and 1,338 NSS Henry Berry Corporation Limited – 420,861 Fully Paid Ordinary Shares and 700 NSS
Class	Ordinary Shares
Number acquired	Indirect: (Sulkem Company Ltd) 1,160 Fully Paid Ordinary Shares
Number disposed	NIL
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$8.94790
No. of securities held after change	Direct: 144,888 Fully Paid Ordinary Shares Indirect: MA Goodfellow – 13,000 Fully Paid Ordinary Shares and 100 NSS St Kentigern Trust – 430,434 Fully Paid Ordinary Shares and 19,727 NSS Sulkem Company Ltd – 130,947 Fully Paid Ordinary Shares Auckland Medical Research Foundation – 26,558 NSS Trustees of The Goodfellow Foundation – 33,854 Fully Paid Ordinary Shares and 1,338 NSS Henry Berry Corporation Limited – 420,861 Fully Paid Ordinary Shares 700 NSS

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Nature of change Shares issued under the Company’s Example: on-market trade, off-market trade, exercise of options, issue of Dividend Reinvestment Plan. securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period **where prior written clearance was required? **	Not Applicable
If so, was prior written clearance provided to allow the trade toproceed during thisperiod?
If prior written clearance was provided, on what date was thisprovided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3